---
schema_version: "secwatch.filing_event.v1"
accession: "0001398733-26-000048"
form_type: "8-K"
ticker: "AQST"
cik: "0001398733"
company_name: "Aquestive Therapeutics, Inc."
filed_at: "2026-09-25T11:59:19+00:00"
generated_at: "2026-10-12T13:18:16.052548+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Aquestive furnishes Sept 23, 2026 investor presentation; 8-K text contains no operational or financial detail

## Summary
- Exhibit 99.1 is titled 'Corporate Presentation' dated September 23, 2026; the appended exhibit text contains only the standard forward-looking-statement disclaimer.
- No revenue, EPS, guidance, clinical-trial or partnership data appears anywhere in the filing or the exhibit text provided.
- Event date listed as September 23, 2026; the 8-K is dated and signed September 25, 2026 by CFO A. Ernest Toth, Jr.
- Company says the deck is available on the Events and Presentations page of the Investors section at www.aquestive.com; content was not reproduced in the filing.
- Cannot summarize substantive news because Exhibit 99.1's body was not included beyond the disclaimer.

## SEC filing metadata
- accession: 0001398733-26-000048
- form_type: 8-K
- ticker: AQST
- cik: 0001398733
- company_name: Aquestive Therapeutics, Inc.
- filed_at: 2026-09-25T11:59:19+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1398733/000139873326000048/0001398733-26-000048-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1398733/000139873326000048/aqst-20260923.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001398733-26-000048
- JSON: https://secwatch.observer/filing/0001398733-26-000048.json
- Plain text: https://secwatch.observer/filing/0001398733-26-000048.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.